Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New research by the Edwards group and collaborators shows that BMP inhibitors are able to reverse the main untreatable symptom of the disease.

The research, led by Dr Sarah Gooding, is an equal collaboration between the groups of Prof Hal Drakesmith at the MRC Human Immunology Unit (RDM) and the group of Prof Claire Edwards at NDORMS and the Nuffield Department of Surgical Sciences.

Read more (MRC Weatherall Institute of Molecular Medicine webiste)

Similar stories

Labelling proteins through the diet gives new insights into how collagen-rich tissues change as we age

A new study, published in eLife, uses advanced tissue analysis technology to show how the incorporation of new proteins changes in bone and cartilage with age.

NDORMS researchers join new multidisciplinary oncology research project

OPTIMA aims to improve treatment for patients with prostate, breast and lung cancer through artificial intelligence

Professor David Beard awarded BOA Honorary Fellowship

Professor of Musculoskeletal and Surgical Science, David Beard, has been awarded an Honorary Fellowship by the British Orthopaedic Association.

Farewell to Angela, NDORMS Head of Administration

Angela Truesdale, who has retired from her role as Head of Administration at NDORMS will be fondly missed by all her colleagues and across the division.

Researchers from the Kennedy Institute awarded MRC funding

Tonia Vincent, Jelena Bezbradica and Alex Clarke have been awarded funding grants by the Medical Research Council (MRC) for different projects.

New guidelines to improve reporting standards of studies that investigate causal mechanisms

Researchers at NDORMS have developed a new set of guidelines for reporting mediation analyses in health research.